20

20n

YC W15

San Francisco, US · 2 employees · Inactive · 1 known investors

20n.com ↗

20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.

Founders & leadership· Y Combinator alumni (W15)

Saurabh Srivastavain𝕏Founder/CEO

Chris AndersoninFounder/CSO

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K